Yoga for Treatment of Overactive Bladder in Pediatric Patients
Overactive Bladder, Overactive Bladder Syndrome, Overactive Detrusor
About this trial
This is an interventional treatment trial for Overactive Bladder focused on measuring bladder, overactive, detrusor, pediatric
Eligibility Criteria
Inclusion Criteria: 8-18 years of age History of non-neurogenic overactive bladder or detrusor overactivity and/or urinary incontinence (ICD 10 codes respectively - N32.81, N39.498) Obtained legally effective informed consent and Health Insurance Portability and Accountability Act (HIPPA) authorization from the participant or the participant's parent/legal guardian Minor participant is willing and able to provide assent (as applicable) Vancouver Dysfunctional Elimination Syndrome[15] score of ≥11 and a positive modified bother score within 30 days of consent Exclusion Criteria: Known or apparent untreated anatomical abnormality of lower urinary tract (i.e. untreated ureterocele) Known neurogenic bladder (e.g., spina bifida, history of spinal cord injury, tethered cord) Nerve damage that may impact pelvic floor function History of chemodenervation of the bladder (e.g., via intravesical instillation or intradetrusor injection of botulinum toxin) Active, untreated UTI at the time of enrollment (UTI undergoing active treatment is allowable) Current or previous pregnancy at screening or planned pregnancy during the duration of the study, for females of childbearing potential Any condition that, in the judgment of the investigator or treating clinician, precludes participation because it could affect participant safety
Sites / Locations
- Duke University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
1.1: 8-12 yoga first
1.2: 13-18 yoga first
2.1: 8-12 yoga second
2.2: 13-18 yoga second